The first-line pharmacological treatment for major depressive disorder (MDD) is antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs). However, a significant proportion of ...
A new study shows that the widely used antidepressant fluoxetine does more than boost serotonin levels: it changes how brain cells manage their energy and rebuild their connections, potentially ...
Barbara Jacquelyn Sahakian receives funding from the Leverhulme Trust and the Lundbeck Foundation. Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback